论著

儿童重症肺炎支原体肺炎与重症肺炎链球菌肺炎的临床特征对比分析

  • 阮金平 ,
  • 符州 ,
  • 颜攀 ,
  • 陈其慧 ,
  • 应林燕
展开
  • 重庆医科大学附属儿童医院呼吸科 国家儿童健康与疾病临床医学研究中心 儿童发育疾病研究教育部重点实验室 儿科学重庆市重点实验室(重庆 400014)

收稿日期: 2023-04-25

  网络出版日期: 2024-06-07

基金资助

重庆医科大学未来医学青年创新团队支持计划(W0063)

Clinical differences between severe Mycoplasma pneumoniae pneumonia and severe Streptococcus pneumoniae pneumonia in children

  • Jinping RUAN ,
  • Zhou FU ,
  • Pan YAN ,
  • Qihui CHEN ,
  • Linyan YING
Expand
  • Department of Respiratory Medicine, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China

Received date: 2023-04-25

  Online published: 2024-06-07

摘要

目的 对比重症肺炎支原体肺炎(MPP)与重症肺炎链球菌肺炎(SPP)的临床特征。方法 回顾性分析2015年1月—2020年1月收治的77例重症MPP和40例重症SPP患儿,对比两组患儿的一般情况、临床表现、辅助检查等资料。结果 重症MPP患儿组男性48例(62.3%),年龄为44(24~78)月。重症SPP患儿组男性22例(55.0%),年龄为14(9~25)月。96.1%(74/77)的重症MPP患儿与80.0%(32/40)的重症SPP患儿在入院前使用抗生素(P=0.007)。与重症SPP患儿相比,重症MPP患儿出现发热、高热比例较高,出现喘息、神经系统症状比例较低(P均<0.05)。重症SPP患儿更易在肺部闻及湿啰音、哮鸣音,且双侧均出现体征患儿比例更高(P均<0.05)。与重症SPP患儿相比,重症MPP患儿WBC较低、LDH水平较高,胸部CT更易出现支气管充气征(均P<0.05)。两组患儿支气管镜镜下表现及肺泡灌洗液常规检查结果的差异无明显统计学意义(P均>0.05)。结论 重症MPP与重症SPP患儿临床特征常不典型,年龄、发热、高热、喘息、肺部体征、神经系统表现、外周血白细胞计数、外周血乳酸脱氢酶水平等对临床鉴别有提 示作用。

本文引用格式

阮金平 , 符州 , 颜攀 , 陈其慧 , 应林燕 . 儿童重症肺炎支原体肺炎与重症肺炎链球菌肺炎的临床特征对比分析[J]. 临床儿科杂志, 2024 , 42(6) : 497 -502 . DOI: 10.12372/jcp.2024.23e0364

Abstract

Objective To compare the differences of clinical features between severe Mycoplasma pneumoniae pneumonia (MPP) and severe Streptococcus pneumoniae pneumonia (SPP). Methods Seventy-seven patients with severe MPP and 40 patients with severe SPP admitted to the respiratory ward of Children's Hospital Affiliated to Chongqing Medical University from January 2015 to January 2020 were retrospectively analyzed, and the general conditions, clinical manifestations, auxiliary examinations and other data of the two groups were compared. Results There were 48 boys (62.3%) in the severe MPP group with a median age of 44(24-78) months. In the severe SPP group, there were 22 boys (55.0%) with a median age of 14(9-25) months. 96.1% (74/77) of children with severe MPP and 80.0% (32/40) of children with severe SPP received antibiotics before admission (P=0.007). Compared with children with severe SPP, the proportion of fever and hyperpyrexia was higher, and the proportion of wheezing and nervous system symptoms was lower in children with severe MPP (P<0.05). The children with severe SPP were more likely to have crackles and rhonchi in the lungs, and the proportion of children with signs on both sides was higher (P<0.05). Compared with children with severe SPP, children with severe MPP had lower WBC and higher LDH levels, and were more likely to have aerated bronchus signs on chest CT (all P<0.05). There was no significant difference in bronchoscopy and routine examination results of bronchoalveolar lavage fluid between the two groups (all P>0.05). Conclusions The clinical characteristics of children with severe MPP and severe SPP are often atypical. Age, fever, hyperpyrexia, wheezing, pulmonary signs, nervous system manifestations, peripheral WBC, and peripheral blood LDH levels are helpful for clinical differentiation.

参考文献

[1] 中华人民共和国国家健康委员会, 国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志, 2019, 12(1): 6-13.
[2] 徐慧, 陈敏, 孙永峰, 等. 贵阳地区儿童重症社区获得性肺炎肺泡灌洗液病原及药敏分析[J]. 广东医学, 2020, 41(23): 2394-2397.
[3] 温志红. 儿童肺炎链球菌肺炎诊断及防治策略[J]. 中国临床新医学, 2021, 14(03): 238-244.
[4] 张慧芬, 李基明, 吴佳音, 等. 儿童侵袭性肺炎链球菌病35例临床特征和分离株耐药性分析[J]. 中国感染与化疗杂志, 2021, 21(2): 152-157.
[5] 刘芳意. 儿童肺炎链球菌下呼吸道感染单中心临床分析[D]. 福建医科大学, 2019.
[6] Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia[J]. Cochrane Database Syst Rev, 2012, 10(10): CD009175.
[7] 尹冰如, 董晓艳. 不同病原感染所致的重症社区获得性肺炎的临床表现[J]. 中国实用儿科杂志, 2022, 37(2): 104-110.
[8] Izumikawa K. Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia[J]. Front Microbiol, 2016, 7:800.
[9] 贺杰, 张新萍. 重症肺炎支原体脑炎的临床特点[J]. 中华实用儿科临床杂志, 2018, 33(12): 884-887.
[10] 王彩云, 许红梅, 邓继岿, 等. 儿童肺炎链球菌脑膜炎临床特征及药物敏感性多中心临床研究[J]. 中华儿科杂志, 2019, 57(5): 355-362.
[11] 常洁, 韩志英, 刘爱红. 不同年龄段儿童肺炎支原体感染所致大叶性肺炎的临床分析[J]. 中国药物与临床, 2018, 18(3): 358-361.
[12] 赵健. 重症肺炎支原体肺炎合并肺外并发症的临床特征及高危因素分析[D]. 天津医科大学, 2020.
[13] 黄璐, 鲍燕敏, 曾洪武. 儿童重症支原体肺炎临床特征及影像学表现[J]. 现代医用影像学, 2020, 29(8): 1571-1573.
[14] 朱美玲. 儿童重症肺炎支原体肺炎的早期预测分析[D]. 吉首大学, 2019.
[15] 刘燕茹, 艾涛, 樊映红, 等. 重症肺炎支原体肺炎临床特点分析及预后评价[J]. 中国妇幼健康研究, 2018, 29(10): 1303-1307.
[16] 姚慧生, 刘立云, 伊丽丽, 等. 儿童重症肺炎支原体肺炎所致塑型性支气管炎的临床特点及危险因素分析[J]. 中国小儿急救医学, 2021, 28(8): 673-678.
[17] 王崇杰, 骆学勤, 罗健, 等. 46例重症肺炎支原体肺炎合并胸腔积液患儿临床及预后分析[J]. 临床儿科杂志, 2020, 38(4): 269-274.
[18] 王倩, 王毅, 杜娈英, 等. 重症肺炎支原体肺炎患儿的临床资料及影像学特点分析[J]. 医学理论与实践, 2019, 32(6): 894-896.
[19] Miyashita N, Sugiu T, Kawai Y, et al. Radiographic features of Mycoplasma pneumoniaepneumonia: differential diagnosis and performance timing[J]. BMC Med Imaging, 2009, 9(1): 7.
[20] 车蓬丽, 胡楠. 纤维支气管镜灌洗术+甲泼尼龙对重症支原体肺炎患儿炎症反应的改善作用[J]. 临床医学研究与实践, 2022, 7(23): 91-94.
[21] 杨俊峰. 支气管镜下肺泡灌洗辅助治疗小儿重症支原体肺炎的临床效果[J]. 中国实用医药, 2020, 15(30): 59-60.
[22] 桂明珠, 王俊芳, 曾娜, 等. 白细胞介素-6、-8、-1β在不同肺炎患儿血清及支气管肺泡灌洗液中的变化及临床意义[J]. 儿科药学杂志, 2020, 26(7): 1-4.
[23] Xing Y, Wang D, Sheng K, et al. Dynamic change of Mycoplasma pneumoniae pneumonia in hospitalized children in a general hospital: a 3-year retrospective analysis[J]. Transl Pediatr, 2020, 9(4): 522-531.
[24] 张贞贞, 柳金德. 支气管镜在早期识别重症肺炎支原体肺炎中的价值[J]. 中国医疗器械信息, 2020, 26(08): 173.
[25] 张琪, 许崇玉, 毕良学. 支气管镜在早期识别重症肺炎支原体肺炎中的价值[J]. 临床肺科杂志, 2019, 24(04): 684-687.
[26] Wang L, Lu S, Feng Z, et al. The early examination of combined serum and imaging data under flexible fiberoptic bronchoscopy as a novel predictor for refractory Mycoplasma pneumoniae pneumonia diagnosis[J]. Medicine (Baltimore), 2017, 96(50): e9364.
文章导航

/